SWP
SGYP

Stratos Wealth Partners’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Stratos Wealth Partners’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,000
Closed -$7K – 2948
2018
Q3 		$7K Buy
+4,000
New +$7.16K ﹤0.01% 2352
2018
Q2 		– Sell
-4,000
Closed -$7K – 3033
2018
Q1 		$7K Hold
4,000
– – ﹤0.01% 2515
2017
Q4 		$9K Buy
+4,000
New +$9.94K ﹤0.01% 2219

Other funds holding SGYP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
OCM
Opti Capital Management New York $1.64B AUM 0% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Stratos Wealth Partners's SGYP Position: Q4 2018 in Review

Stratos Wealth Partners sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 4,000 shares — an estimated $7K sold.

Stratos Wealth Partners first reported a position in SGYP in Q4 2017 and held it in 3 quarters. The position peaked at $9K in Q4 2017. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

  • Stratos Wealth Partners reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
  • Stratos Wealth Partners sold 4,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $7K.
  • Stratos Wealth Partners first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2017 and held it in 3 quarters.
  • Stratos Wealth Partners's Synergy Pharmaceuticals, Inc Common Stock position peaked at $9K in Q4 2017.
  • 89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on Stratos Wealth Partners's 13F filing for Q4 2018, filed 8 Feb 2019.